Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-22T16:33:22.250Z Has data issue: false hasContentIssue false
  • English
  • Français

Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease – CORRIGENDUM

Published online by Cambridge University Press:  23 May 2024

Rong Ma ,
Guangying Shi ,
Yanfang Li  and
Han Shi
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Corrigendum
Information
British Journal of Nutrition , Volume 131 , Issue 11 , 14 June 2024 , pp. 1924 - 1925
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society

The authors regret errors in Figure 3 (page 6).

Fig. 3. Receiver operating characteristic curves of traditional risk factors (blue) plus TMAO, choline and its related metabolites (red) for NAFLD. NAFLD, non-alcoholic fatty liver disease; TMAO, trimethylamine N-oxide.

Fig. 3. Receiver operating characteristic curves of traditional risk factors (red) plus TMAO, choline and its related metabolites (blue) for NAFLD. NAFLD, non-alcoholic fatty liver disease; TMAO, trimethylamine N-oxide.

The correct labels are

[red line] Traditional risk factors

[blue line] Traditional risk factors + TMAO, choline and its precursors

The caption of the figure erroneously identified the red and blue lines. The correct caption is

Fig. 3. Receiver operating characteristic curves of traditional risk factors (red) plus TMAO, choline and its related metabolites (blue) for NAFLD. NAFLD, non-alcoholic fatty liver disease; TMAO, trimethylamine N-oxide.

References

Ma, R. et al. (2024) ‘Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease’, British Journal of Nutrition, pp. 1–9. doi: 10.1017/S0007114524000631.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 3. Receiver operating characteristic curves of traditional risk factors (blue) plus TMAO, choline and its related metabolites (red) for NAFLD. NAFLD, non-alcoholic fatty liver disease; TMAO, trimethylamine N-oxide.

Figure 1

Fig. 3. Receiver operating characteristic curves of traditional risk factors (red) plus TMAO, choline and its related metabolites (blue) for NAFLD. NAFLD, non-alcoholic fatty liver disease; TMAO, trimethylamine N-oxide.